NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer

NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer

Abstract Background Robotic radical prostatectomy (RARP) is a first-line curative treatment option for localized prostate cancer. Postoperative erectile dysfunction and urinary incontinence are common associated adverse side effects that can negatively impact patients’ quality of life. Preserving th...

Full description

Bibliographic Details
Main Authors: Eoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, Rosie Clow, Aiman Haider, Clare Allen, Daniel Heffernan-Ho, Alex Freeman, Tim Briggs, Senthil Nathan, Susan Mallett, Chris Brew-Graves, Nicola Muirhead, Norman R. Williams, Elena Pizzo, Raj Persad, Jon Aning, Lyndsey Johnson, Jon Oxley, Neil Oakley, Susan Morgan, Fawzia Tahir, Imran Ahmad, Lorenzo Dutto, Jonathan M. Salmond, Anand Kelkar, John Kelly, Greg Shaw
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Trials
Subjects:
NeuroSAFE
Nerve sparing
Frozen section
Potency
Robotic prostatectomy
Prostate cancer
Online Access:https://doi.org/10.1186/s13063-022-06421-7

Internet

https://doi.org/10.1186/s13063-022-06421-7

Similar Items